MDL Judge Issues CMO #3 Allowing Direct Filing of Suboxone Lawsuits The Multidistrict Litigation (MDL) judge has issued Case Management Order (CMO) #3, outlining key procedures for the MDL involving Suboxone lawsuits. One of the most notable changes is the allowance for plaintiffs’ attorneys to file their Suboxone-related cases directly into the MDL, bypassing the…
Leadership Appointed in Suboxone MDL The initial status conference for the Suboxone tooth decay lawsuit was held on March 7, 2024, before Judge Philip Calabrese in the United States District Court for the Southern District of Ohio. Matthew Dolman and Stanley Gipe from Dolman Law Group attended, with Stanley Gipe appointed to the Plaintiff’s Steering…
A group of 18 lawyers representing plaintiffs in Suboxone tooth decay lawsuits have submitted a consensus motion for the plaintiffs’ leadership committee. This committee will take actions that benefit all individuals pursuing legal action over tooth decay caused by Suboxone. Judge Appointed to Preside Over Suboxone Tooth Decay Lawsuits Recently appointed U.S. District Judge Philip…
Ohio Man Files New Suboxone Lawsuit in MDL In a recent development within the Multi-District Litigation (MDL) for Suboxone lawsuits, an Ohio man has filed a new case. The plaintiff reports being prescribed Suboxone as part of his treatment and adhering to the prescribed regimen. Despite his compliance, he experienced significant dental damage directly linked…
As of February 2024, there have been no public announcements regarding court-approved settlements for Suboxone cases related to dental problems, nor have any trials been scheduled. The U.S. Judicial Panel on Multidistrict Litigation has decided to consolidate more than a dozen Suboxone tooth decay lawsuits into multidistrict litigation (MDL) within the Northern District of Ohio….
The U.S. Judicial Panel on Multidistrict Litigation has mandated the consolidation of more than a dozen Suboxone tooth decay lawsuits into multidistrict litigation (MDL) in the Northern District of Ohio. Allegations from Suboxone lawsuits suggest that the drug’s sublingual formula, characterized by its high acidity, can lead to dental complications like tooth decay, erosion, and…
The realm of Suboxone, an opioid disorder treatment drug, has recently witnessed an emerging wave of lawsuits. These legal actions assert that Suboxone, while designed to alleviate opioid dependency, has led to a host of serious dental issues including tooth decay, oral infections, cavities, and even tooth loss. Claimants argue that the manufacturer, Indivior, failed…
Indivior, the manufacturer of Suboxone, has reached a $385 million settlement to resolve a prolonged antitrust lawsuit, marking a significant step towards concluding over a decade of legal battles. The lawsuit, filed by a group of direct purchasers of the opioid use disorder drug, accused Indivior of unlawfully attempting to monopolize opioid addiction treatment with…
A panel of federal judges is set to convene in California on January 25, 2024, to hear oral arguments regarding the consolidation of 15 Suboxone tooth decay lawsuits into multidistrict litigation (MDL). This decision comes following a joint motion by plaintiffs’ attorneys and the drug’s manufacturer, Indivior, seeking coordinated discovery and pretrial proceedings. Background Leading…